Clinical Trials Industry in India: A Systematic Review

Dinesh Abrol and Swadhin Mondal

Working Papers from eSocialSciences

Abstract: This study shows that many global clinical trials organisations have relocated their clinical trial (CT) research units to India. The Indian CT industry has become one of the most cost-efficient destinations in the world. It is growing fast and has emerged as a popular destination for global clinical trials. However, the process followed by the pharmaceutical companies for conducting CTs has raised some critical issues. The authors of this paper argue that the Government of India needs to establish a policy framework for the Indian CT industry to provide for easy access to affordable drugs developed through adaptive clinical trials and create a regulatory environment capable of ensuring the conduct of clinical trials without violation of humanitarian ethics and other social norms.

Keywords: Economics; Clinical Research; Ethics; Regulation; India; Healthcare; Social Norms; Policy Maker (search for similar items in EconPapers)
Date: 2015-07
Note: Institutional Papers
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.esocialsciences.org/Download/repecDownl ... &AId=7160&fref=repec

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ess:wpaper:id:7160

Access Statistics for this paper

More papers in Working Papers from eSocialSciences
Bibliographic data for series maintained by Padma Prakash ().